A Conversation with Acromegaly Patient Advocates

We recently sat down with members of the acromegaly community to discuss their treatment journeys and the lessons they learned along the way, including...

Big news for acromegaly at Crinetics

From the desk of J D Faccinetti - co-founder - The company recently kicked off a phase 3 trial for their new nonpeptide oral...

Pregnancy and acromegaly

Acromegaly: what to do with medical treatment during pregnancy and the options available today.
video

The ride for acromegaly

From Jorge D. Faccinetti - co-founder.  With a pituitary disease like acromegaly, Cushing's, hypopituitarism, and others, or for that matter, any other chronic condition,...

A talk with Crinetics Chairman Scott Struthers, Ph.D.

During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients. From the J D Faccinetti, co-founder...

A discussion on telemedicine and pituitary disease

Important changes in telehealth visit regulations provide an excellent opportunity for patients to receive consultations from highly experienced specialists in pituitary disease. Read on! On...

A note on the importance of awareness

Tell us what is like to live with acromegaly From J D Faccinetti – co-founder and chief editor:  In the awareness business, coming up with new,...

Day time TV tackles acromegaly

Pituitary World News' main goal is to increase awareness of pituitary disease so more people are diagnosed early and properly.  So when a daytime...

Hello, Pills!

With the recent approval and commercial launch of MYCAPSSA®, Chiasma delivers the first and only oral somatostatin analog to treat acromegaly. The research showed...

The amazing possibilities of facial recognition technology.

Dr. Manel Puig Domingo, a leading endocrinologist in Barcelona, is doing important work on facial recognition and biometrics to see if this technology is...

NEWS YOU CAN USE

Articles you may like